SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/E79681733C68D74ADF30019D9F1AC856FE14E240F2A0AF8057B783A05CA82D8878137144F0F95724BCE307BE49830D6C>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/E79681733C68D74ADF30019D9F1AC856FE14E240F2A0AF8057B783A05CA82D8878137144F0F95724BCE307BE49830D6C
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/E79681733C68D74ADF30019D9F1AC856FE14E240F2A0AF8057B783A05CA82D8878137144F0F95724BCE307BE49830D6C
http://www.w3.org/2000/01/rdf-schema#comment
"These results clearly provide additional in vivo evidence that prasugrel has selective P2Y(12) antagonistic activity."
xsd:string
http://purl.uniprot.org/uniprot/#_4095D241B1FF1E257AF0737FDDF29C184C93148D1DDD1D0A2F370497F0DFD2745E4A4B932C2670FE3BA8D98C44C41BB1
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/E79681733C68D74ADF30019D9F1AC856FE14E240F2A0AF8057B783A05CA82D8878137144F0F95724BCE307BE49830D6C
http://purl.uniprot.org/uniprot/Q546L4
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/E79681733C68D74ADF30019D9F1AC856FE14E240F2A0AF8057B783A05CA82D8878137144F0F95724BCE307BE49830D6C
http://purl.uniprot.org/uniprot/#_Q546L4-mappedCitation-17681285
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/E79681733C68D74ADF30019D9F1AC856FE14E240F2A0AF8057B783A05CA82D8878137144F0F95724BCE307BE49830D6C